Patients with Chronic Lymphocytic Leukemia (CLL) are better off with a combination of ibrutinib and venetoclax. This is more effective than the standard treatment, researchers of Amsterdam UMC discovered.
Amsterdam UMC is a global pioneer in the area of 3D printing with living tissue. This means our researchers have to invent almost everything themselves.
It is sometimes difficult to measure the impact of scientific research on people and society. But it is very clear with Connie Bezzina: her research has important consequences for people who can die at a young age from sudden cardiac arrest without any warning.